BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 32493915)

  • 1. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
    Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
    J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies.
    Zhou Y; Chen S; Cheng S; Wei Q; Fathy AH; Shan T
    Clin Chim Acta; 2018 Jun; 481():147-153. PubMed ID: 29544748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA TP73-AS1 in cancers.
    Gong CY; Tang R; Liu KX; Xiang G; Zhang HH
    Clin Chim Acta; 2020 Apr; 503():151-156. PubMed ID: 31978409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.
    Ren X; He J; Qi L; Li S; Zhang C; Duan Z; Wang W; Tu C; Li Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):353-361. PubMed ID: 31899963
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
    Tang L; Liu QM; Zhang S; Zhou J
    Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
    Zhou X; Fan YH; Wang Y; Wang F; Liu Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.